Lifestyle Intervention in Pregnant Women With PCOS

Sponsor
Capital Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04216485
Collaborator
(none)
296
1
2
35.9
8.2

Study Details

Study Description

Brief Summary

Polycystic ovarian syndrome (PCOS) is the most common reproductive disorder in women of childbearing age and is also associated with metabolic abnormalities including obesity, type 2 diabetes, dyslipidemia, etc. Importantly, a number of adverse outcome are seen in pregnancies complicated by PCOS, including gestational diabetes mellitus (GDM), preeclampsia and miscarriage. However, optimal management of PCOS complicated pregnancy is not known. This study seeks to explore whether healthy lifestyle intervention in overweight/obese pregnant women with PCOS could reduce gestational weight gain (GWG) and incidence of GDM.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intensive Lifestyle Intervention
  • Behavioral: Standard Care
N/A

Detailed Description

A randomized controlled trial in PCOS pregnant women will be initiated at 8-12 weeks of gestation util delivery. Participants will be randomly assigned to the control group (standard care) or the intervention group (intensive lifestyle intervention). The intervention will focus on restricting energy intake combined with behavioral lifestyle modification through participation in group sessions and individual counseling. The primary outcome will be GWG and secondary outcome will be the incidence of GDM.

Our hypothesis is that intensive lifestyle intervention in overweight/obese pregnant women with PCOS will decrease GWG and reduce the incidence of GDM.

Study Design

Study Type:
Interventional
Actual Enrollment :
296 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Intensive Lifestyle Intervention on Gestational Weight Gain and Development of Gestational Diabetes Mellitus in Overweight/Obese Pregnant Women With a History of Polycystic Ovarian Syndrome
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Sep 30, 2019
Actual Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lifestyle intervention

Intervention group: Intensive lifestyle intervention will be initiated from the first trimester (8-12wks) to delivery, with follow up every 2-4 weeks. Participants in the intervention group will be provided with an individualized dietary protocol with not less than 1500 calories per day in the first trimester and not less than 1800 calories per day after 13 weeks of gestation. Guidance on regular exercise is reinforced at the first and each follow up visit.

Behavioral: Intensive Lifestyle Intervention
Dietary intervention combined with healthy lifestyle counseling

Active Comparator: Standard Care

Standard care group: Participants will receive a 1.5-hour group session in which standard prenatal intervention on diet, nutrition and physical activity and recommendation for gestational weight gain are reviewed by a registered dietitian. Thereafter, participants will receive their regularly scheduled follow up visits without additional lifestyle guidance.

Behavioral: Standard Care
Standard prenatal care on diet, nutrition and physical activity

Outcome Measures

Primary Outcome Measures

  1. Gestational weight gain [From date of randomization until the date of delivery, assessed up to 9 months]

Secondary Outcome Measures

  1. Incidence of Gestational Diabetes Mellitus [From enrollment to 24-28 weeks of gestation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • gestational age between 8 and 12 weeks of gestation, pre-pregnancy BMI≥25 (kg/m2)

  • age ≥18 years, and a singleton pregnancy.

Exclusion Criteria:
  • patients with prediabetes and diabetes, hypertension, chronic renal disease, thyroid disorder

  • gestational weeks ≥ 13

  • age <18 years

  • multiple pregnancy

  • uterine malformation

  • or physical restriction that prevents exercise.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Obstetrics and Gynecology Hospital,Capital Medical University Beijing China 100026

Sponsors and Collaborators

  • Capital Medical University

Investigators

  • Principal Investigator: Guanghui Li, MD, PhD, Beijing Obstetrics and Gynecology Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guanghui Li, Associate Professor, Capital Medical University
ClinicalTrials.gov Identifier:
NCT04216485
Other Study ID Numbers:
  • Z161100000516160
  • Z16110700050000
First Posted:
Jan 2, 2020
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2021